Rituximab in the Treatment of Bullous Systemic Lupus Erythematosus

Bullous systemic lupus erythematosus: revised criteria for diagnosis

(2010) J.A. YELL et al.   BRITISH JOURNAL OF DERMATOLOGY

B Cell-Targeted Therapies for Systemic Lupus Erythematosus

(2010) R. John Looney   DRUGS

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

Rituximab in non-haematological disorders of adults and its mode of action

(2009) Vickie McDonald et al.   BRITISH JOURNAL OF HAEMATOLOGY

Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases

(2009) M Ramos-Casals et al.   LUPUS

A perspective on B-cell-targeting therapy for SLE

(2009) R. John Looney et al.   Modern Rheumatology

Rituximab-induced B cell depletion in autoimmune diseases: Potential effects on T cells

(2008) Stamatis-Nick C. Liossis et al.   CLINICAL IMMUNOLOGY